Lawyers for Arkansas and Johnson & Johnson make closing arguments in trial over Risperdal drug

Johnson & Johnson hid the risks of the antipsychotic drug Risperdal to boost sales and should be held liable for misleading Arkansas doctors and patients, one of the state's lawyers told a jury in Little Rock today.

J&J's Janssen unit made misleading claims about Risperdal's effectiveness in a letter to more than 6,000 Arkansas doctors and downplayed its diabetes risks on warning labels, lawyer